{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:24:06Z","timestamp":1790915046278,"version":"4.1.0"},"reference-count":49,"publisher":"American Association for Cancer Research (AACR)","issue":"15","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The indole-3-carbinol (I3C) metabolite 3,3\u2032-diindolylmethane (DIM) is a proposed cancer prevention agent for various tumor types, including breast cancer. Here, we show that DIM up-regulates expression of the tumor suppressor protein BRCA1 in carcinoma and normal cell types. Up-regulation of BRCA1 was dose and time dependent, and it was observed at physiologically relevant micromolar and submicromolar DIM concentrations when cells were exposed for 72 hours. Treatment with the parent compound (I3C) or DIM (1 \u03bcmol\/L) protected against cell killing due to H2O2 and other oxidants, and the protection was abrogated by knockdown of BRCA1. DIM stimulated signaling by the antioxidant transcription factor NFE2L2 (NRF2) through the antioxidant response element in a BRCA1-dependent manner. We further showed that DIM rapidly stimulated phosphorylation of BRCA1 on Ser 1387 and Ser 1524 and that these phosphorylations are required for protection against oxidative stress. DIM-induced phosphorylation of BRCA1 on Ser 1387 was dependent on ataxia-telangiectasia mutated. Finally, in our assay systems, H2O2-induced cell death was not due to apoptosis. However, a significant component of cell death was attributable to autophagy, and both DIM and BRCA1 inhibited H2O2-induced autophagy. Our findings suggest that low concentrations of DIM protect cells against oxidative stress via the tumor suppressor BRCA1 by several distinct mechanisms. [Cancer Res 2009;69(15):6083\u201391]<\/jats:p>","DOI":"10.1158\/0008-5472.can-08-3309","type":"journal-article","created":{"date-parts":[[2009,7,21]],"date-time":"2009-07-21T22:24:10Z","timestamp":1248215050000},"page":"6083-6091","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Low Concentrations of Diindolylmethane, a Metabolite of Indole-3-Carbinol, Protect against Oxidative Stress in a BRCA1-Dependent Manner"],"prefix":"10.1158","volume":"69","author":[{"given":"Saijun","family":"Fan","sequence":"first","affiliation":[{"name":"1Oncology, Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghui","family":"Meng","sequence":"additional","affiliation":[{"name":"1Oncology, Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapas","family":"Saha","sequence":"additional","affiliation":[{"name":"1Oncology, Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazlul H.","family":"Sarkar","sequence":"additional","affiliation":[{"name":"4Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliot M.","family":"Rosen","sequence":"additional","affiliation":[{"name":"1Oncology, Departments of"},{"name":"2Biochemistry, and"},{"name":"3Radiation Medicine, Georgetown University, Washington, District of Columbia and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2009,7,29]]},"reference":[{"key":"2022061701481121200_B1","doi-asserted-by":"crossref","unstructured":"Higdon JV, Delage B, Williams DE, Dashwood RH. Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis [review]. Pharmacol Res\u20082007; 55: 224\u201336.","DOI":"10.1016\/j.phrs.2007.01.009"},{"key":"2022061701481121200_B2","doi-asserted-by":"crossref","unstructured":"Graham S, Marshall J, Mettlin C, Rzepka T, Nemoto T, Byers T. Diet in the epidemiology of breast cancer. Am J Epidemiol\u20081982; 116: 68\u201375.","DOI":"10.1093\/oxfordjournals.aje.a113403"},{"key":"2022061701481121200_B3","doi-asserted-by":"crossref","unstructured":"Bradlow HL, Michnovicz J, Telang NT, Osborne MP. Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis\u20081991; 12: 1571\u20134.","DOI":"10.1093\/carcin\/12.9.1571"},{"key":"2022061701481121200_B4","unstructured":"Kojima T, Tanaka T, Mori H. Chemoprevention of spontaneous endometrial cancer in female Donryu rats by indole-3-carbinol. Cancer Res\u20081994; 54: 1446\u20139."},{"key":"2022061701481121200_B5","unstructured":"Jin L, Qi M, Chen DZ, et al. Indole-3-carbinol prevents cervical cancer in human papilloma virus type 16 (HPV16) transgenic mice. Cancer Res\u20081999; 59: 3991\u20137."},{"key":"2022061701481121200_B6","unstructured":"Rogan EG. The natural chemopreventive compound indole-3-carbinol: state of the science [review]. In Vivo\u20082006; 20: 221\u20138."},{"key":"2022061701481121200_B7","doi-asserted-by":"crossref","unstructured":"Anderton MJ, Manson MM, Verschoyle R, et al. Physiological modeling of formulated and crystalline 3,3\u2032-diindolylmethane pharmacokinetics following oral administration in mice. Drug Metab Dispos\u20082004; 32: 632\u20138.","DOI":"10.1124\/dmd.32.6.632"},{"key":"2022061701481121200_B8","doi-asserted-by":"crossref","unstructured":"Reed GA, Arneson DW, Putnam WC, et al. Single-dose and multiple-dose administration of indole-3-carbinol to women: pharmacokinetics based on 3,3\u2032-diindolylmethane. Cancer Epidemiol Biomarkers Prev\u20082006; 15: 2477\u201381.","DOI":"10.1158\/1055-9965.EPI-06-0396"},{"key":"2022061701481121200_B9","doi-asserted-by":"crossref","unstructured":"Kong D, Banerjee S, Huang W, et al. Mammalian target of rapamycin repression by 3,3\u2032-diindolylmethane inhibits invasion and angiogenesis in platelet-derived growth factor-D-overexpressing PC3 cells. Cancer Res\u20082008; 68: 1927\u201334.","DOI":"10.1158\/0008-5472.CAN-07-3241"},{"key":"2022061701481121200_B10","doi-asserted-by":"crossref","unstructured":"Li Y, Wang Z, Kong D, et al. Regulation of FOXO3a\/\u03b2-catenin\/GSK-3\u03b2 signaling by 3,3\u2032-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells. J Biol Chem\u20082007; 282: 21542\u201350.","DOI":"10.1074\/jbc.M701978200"},{"key":"2022061701481121200_B11","doi-asserted-by":"crossref","unstructured":"Garikapaty VP, Ashok BT, Tadi K, Mittelman A, Tiwari RK. 3,3\u2032-Diindolylmethane downregulates pro-survival pathway in hormone independent prostate cancer. Biochem Biophys Res Commun\u20082006; 340: 718\u201325.","DOI":"10.1016\/j.bbrc.2005.12.059"},{"key":"2022061701481121200_B12","doi-asserted-by":"crossref","unstructured":"Firestone GL, Bjeldanes LF. Indole-3-carbinol and 3-3\u2032-diindolylmethane antiproliferative signaling pathways control cell-cycle gene transcription in human breast cancer cells by regulating promoter-Sp1 transcription factor interactions [review]. J Nutr\u20082003; 133: 2448\u201355S.","DOI":"10.1093\/jn\/133.7.2448S"},{"key":"2022061701481121200_B13","doi-asserted-by":"crossref","unstructured":"Mulvey L, Chandrasekaran A, Liu K, et al. Interplay of genes regulated by estrogen and diindolylmethane in breast cancer cell lines. Mol Med\u20082007; 13: 69\u201378.","DOI":"10.2119\/2006-00038.Mulvey"},{"key":"2022061701481121200_B14","doi-asserted-by":"crossref","unstructured":"Carter TH, Liu K, Ralph W, Jr., et al. Diindolylmethane alters gene expression in human keratinocytes in vitro. J Nutr\u20082002; 132: 3314\u201324.","DOI":"10.1093\/jn\/132.11.3314"},{"key":"2022061701481121200_B15","doi-asserted-by":"crossref","unstructured":"Sun S, Han J, Ralph WM, Jr., et al. Endoplasmic reticulum stress as a correlate of cytotoxicity in human tumor cells exposed to diindolylmethane in vitro. Cell Stress Chaperones\u20082004; 9: 76\u201387.","DOI":"10.1379\/CSC-2R.1"},{"key":"2022061701481121200_B16","doi-asserted-by":"crossref","unstructured":"Dalessandri KM, Firestone GL, Fitch MD, Bradlow HL, Bjeldanes LF. Pilot study: effect of 3,3\u2032-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer. Nutr Cancer\u20082004; 50: 161\u20137.","DOI":"10.1207\/s15327914nc5002_5"},{"key":"2022061701481121200_B17","doi-asserted-by":"crossref","unstructured":"Le HT, Schaldach CM, Firestone GL, Bjeldanes LF. Plant-derived 3,3\u2032-diindolylmethane is a strong androgen antagonist in human prostate cancer cells. J Biol Chem\u20082003; 278: 21136\u201345.","DOI":"10.1074\/jbc.M300588200"},{"key":"2022061701481121200_B18","doi-asserted-by":"crossref","unstructured":"Jellinck PH, Forkert PG, Riddick DS, Okey AB, Michnovicz JJ, Bradlow HL. Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation. Biochem Pharmacol\u20081993; 45: 1129\u201336.","DOI":"10.1016\/0006-2952(93)90258-X"},{"key":"2022061701481121200_B19","doi-asserted-by":"crossref","unstructured":"Chen I, Safe S, Bjeldanes L. Indole-3-carbinol and diindolylmethane as aryl hydrocarbon (Ah) receptor agonists and antagonists in T47D human breast cancer cells. Biochem Pharmacol\u20081996; 51: 1069\u201376.","DOI":"10.1016\/0006-2952(96)00060-3"},{"key":"2022061701481121200_B20","doi-asserted-by":"crossref","unstructured":"Meng Q, Yuan F, Goldberg ID, Rosen EM, Auborn K, Fan S. Indole-3-carbinol is a negative regulator of estrogen receptor-\u03b1 signaling in human tumor cells. J Nutr\u20082000; 130: 2927\u201331.","DOI":"10.1093\/jn\/130.12.2927"},{"key":"2022061701481121200_B21","doi-asserted-by":"crossref","unstructured":"De Kruif CA, Marsman JW, Venekamp JC, et al. Structure elucidation of acid reaction products of indole-3-carbinol: detection in vivo and enzyme induction in vitro. Chem Biol Interact\u20081991; 80: 303\u201315.","DOI":"10.1016\/0009-2797(91)90090-T"},{"key":"2022061701481121200_B22","doi-asserted-by":"crossref","unstructured":"Fan S, Meng Q, Auborn K, Carter T, Rosen EM. BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells. Br J Cancer\u20082006; 94: 407\u201326.","DOI":"10.1038\/sj.bjc.6602935"},{"key":"2022061701481121200_B23","doi-asserted-by":"crossref","unstructured":"Xu X, Weaver Z, Linke SP, et al. Centrosome amplification and a defective G 2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol Cell\u20081999; 3: 389\u201395.","DOI":"10.1016\/S1097-2765(00)80466-9"},{"key":"2022061701481121200_B24","doi-asserted-by":"crossref","unstructured":"Bae I, Fan S, Meng Q, et al. BRCA1 induces antioxidant gene expression and resistance to oxidative stress. Cancer Res\u20082004; 64: 7893\u2013909.","DOI":"10.1158\/0008-5472.CAN-04-1119"},{"key":"2022061701481121200_B25","doi-asserted-by":"crossref","unstructured":"Akar U, Ozpolat B, Mehta K, Fok J, Kondo Y, Lopez-Berestein G. Tissue transglutaminase inhibits autophagy in pancreatic cancer cells. Mol Cancer Res\u20082007; 5: 241\u20139.","DOI":"10.1158\/1541-7786.MCR-06-0229"},{"key":"2022061701481121200_B26","doi-asserted-by":"crossref","unstructured":"Bloom D, Dhakshinamoorthy S, Jaiswal AK. Site-directed mutagenesis of cysteine to serine in the DNA binding region of Nrf2 decreases its capacity to up-regulate antioxidant response element-mediated expression and antioxidant induction of NAD-(P)H:quinone oxidoreductase 1 gene. Oncogene\u20082002; 21: 2191\u2013200.","DOI":"10.1038\/sj.onc.1205288"},{"key":"2022061701481121200_B27","doi-asserted-by":"crossref","unstructured":"Faraonio R, Vergara P, Di Marzo D, et al. p53 suppresses the Nrf2-dependent transcription of antioxidant response genes. J Biol Chem\u20082006; 281: 39776\u201384.","DOI":"10.1074\/jbc.M605707200"},{"key":"2022061701481121200_B28","unstructured":"Alley MC, Scudiero DA, Monks A, et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res\u20081988; 48: 589\u2013601."},{"key":"2022061701481121200_B29","unstructured":"Biederbick A, Kern HF, Elsa\u0308sser HP. Monodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles. Eur J Cell Biol\u20081995; 66: 3\u201314."},{"key":"2022061701481121200_B30","doi-asserted-by":"crossref","unstructured":"Costa M, Salnikow K, Sutherland JE, et al. The role of oxidative stress in nickel and chromate genotoxicity [review]. Mol Cell Biochem\u20082002; 234-235: 265\u201375.","DOI":"10.1007\/978-1-4615-1087-1_30"},{"key":"2022061701481121200_B31","doi-asserted-by":"crossref","unstructured":"Smith LL. Mechanism of paraquat toxicity in lung and its relevance to treatment [review]. Hum Toxicol\u20081987; 6: 31\u20136.","DOI":"10.1177\/096032718700600105"},{"key":"2022061701481121200_B32","doi-asserted-by":"crossref","unstructured":"Nguyen T, Sherratt PJ, Pickett CB. Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu Rev Pharmacol Toxicol\u20082003; 43: 233\u201360.","DOI":"10.1146\/annurev.pharmtox.43.100901.140229"},{"key":"2022061701481121200_B33","doi-asserted-by":"crossref","unstructured":"Kelner MJ, Bagnell RD, Montoya MA, Estes LA, Forsberg L, Morgenstern R. Structural organization of the microsomal glutathione S-transferase gene (MGST1) on chromosome 12p13.1-13.2. Identification of the correct promoter region and demonstration of transcriptional regulation in response to oxidative stress. J Biol Chem\u20082000; 275: 13000\u20136.","DOI":"10.1074\/jbc.275.17.13000"},{"key":"2022061701481121200_B34","unstructured":"Tomlinson GE, Chen TT, Stastny VA, et al. Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier. Cancer Res\u20081998; 58: 3237\u201342."},{"key":"2022061701481121200_B35","unstructured":"Tait L, Soule HD, Russo J. Ultrastructural and immunocytochemical characterization of an immortalized human breast epithelial cell line, MCF-10. Cancer Res\u20081990; 50: 6087\u201394."},{"key":"2022061701481121200_B36","doi-asserted-by":"crossref","unstructured":"Asanuma K, Tanida I, Shirato I, et al. MAP-LC3, a promising autophagosomal marker, is processed during the differentiation and recovery of podocytes from PAN nephrosis. FASEB J\u20082003; 17: 1165\u20137.","DOI":"10.1096\/fj.02-0580fje"},{"key":"2022061701481121200_B37","doi-asserted-by":"crossref","unstructured":"Bampton ET, Goemans CG, Niranjan D, Mizushima N, Tolkovsky AM. The dynamics of autophagy visualized in live cells: from autophagosome formation to fusion with endo\/lysosomes. Autophagy\u20082005; 1: 23\u201336.","DOI":"10.4161\/auto.1.1.1495"},{"key":"2022061701481121200_B38","doi-asserted-by":"crossref","unstructured":"Gopalakrishnan A, Tony Kong AN. Anticarcinogenesis by dietary phytochemicals: cytoprotection by Nrf2 in normal cells and cytotoxicity by modulation of transcription factors NF-\u03baB and AP-1 in abnormal cancer cells. Food Chem Toxicol\u20082008; 46: 1257\u201370. Review.","DOI":"10.1016\/j.fct.2007.09.082"},{"key":"2022061701481121200_B39","unstructured":"Xu B, O'Donnell AH, Kim ST, Kastan MB. Phosphorylation of serine 1387 in Brca1 is specifically required for the Atm-mediated S-phase checkpoint after ionizing irradiation. Cancer Res\u20082002; 62: 4588\u201391."},{"key":"2022061701481121200_B40","doi-asserted-by":"crossref","unstructured":"Gatei M, Zhou BB, Hobson K, Scott S, Young D, Khanna KK. Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of Brca1 at distinct and overlapping sites. In vivo assessment using phospho-specific antibodies. J Biol Chem\u20082001; 276: 17276\u201380.","DOI":"10.1074\/jbc.M011681200"},{"key":"2022061701481121200_B41","doi-asserted-by":"crossref","unstructured":"Scherz-Shouval R, Elazar Z. ROS, mitochondria and the regulation of autophagy. Trends Cell Biol\u20082007; 17: 422\u20137.","DOI":"10.1016\/j.tcb.2007.07.009"},{"key":"2022061701481121200_B42","doi-asserted-by":"crossref","unstructured":"Chen Y, McMillan-Ward E, Kong J, Israels SJ, Gibson SB. Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells. Cell Death Differ\u20082008; 15: 171\u201382.","DOI":"10.1038\/sj.cdd.4402233"},{"key":"2022061701481121200_B43","doi-asserted-by":"crossref","unstructured":"Kurz T, Terman A, Gustafsson B, Brunk UT. Lysosomes and oxidative stress in aging and apoptosis [review]. Biochim Biophys Acta\u20082008; 1780: 1291\u2013303.","DOI":"10.1016\/j.bbagen.2008.01.009"},{"key":"2022061701481121200_B44","doi-asserted-by":"crossref","unstructured":"Liang XH, Jackson S, Seaman M, et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature\u20081999; 402: 672\u20136.","DOI":"10.1038\/45257"},{"key":"2022061701481121200_B45","doi-asserted-by":"crossref","unstructured":"Gudmundsdottir K, Ashworth A. The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability [review]. Oncogene\u20082006; 25: 5864\u201374.","DOI":"10.1038\/sj.onc.1209874"},{"key":"2022061701481121200_B46","doi-asserted-by":"crossref","unstructured":"Lawenda BD, Kelly KM, Ladas EJ, Sagar SM, Vickers A, Blumberg JB. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst\u20082008; 100: 773\u20133.","DOI":"10.1093\/jnci\/djn148"},{"key":"2022061701481121200_B47","doi-asserted-by":"crossref","unstructured":"Engel RH, Evens AM. Oxidative stress and apoptosis: a new treatment paradigm in cancer [review]. Front Biosci\u20082006; 11: 300\u201312.","DOI":"10.2741\/1798"},{"key":"2022061701481121200_B48","unstructured":"Cabello CM, Bair WB III, Wondrak GT. Experimental therapeutics: targeting the redox Achilles heel of cancer [review]. Curr Opin Investig Drugs\u20082007; 8: 1022\u201337."},{"key":"2022061701481121200_B49","doi-asserted-by":"crossref","unstructured":"Eisenberg-Lerner A, Kimchi A. The paradox of autophagy and its implication in cancer etiology and therapy. Apoptosis\u20082009; 14: 376\u201391.","DOI":"10.1007\/s10495-008-0307-5"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/15\/6083\/2867064\/6083.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/15\/6083\/2867064\/6083.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T04:59:56Z","timestamp":1655441996000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/69\/15\/6083\/549802\/Low-Concentrations-of-Diindolylmethane-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,29]]},"references-count":49,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2009,7,29]]},"published-print":{"date-parts":[[2009,8,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-08-3309","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6498660","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22377669.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6498660.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22377666.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22377666","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22377669","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,29]]}}}